Filing Details
- Accession Number:
- 0000014272-14-000216
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-30 16:40:23
- Reporting Period:
- 2014-07-28
- Filing Date:
- 2014-07-30
- Accepted Time:
- 2014-07-30 16:40:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1561017 | J Samuel Moed | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Svp, Strat Plan & Analysis | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Acquisiton | 2014-07-28 | 19,650 | $27.01 | 59,652 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2014-07-28 | 25,752 | $49.32 | 33,900 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Option (right to buy) | Disposition | 2014-07-28 | 19,650 | $0.00 | 19,650 | $27.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-03-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.10 Par Value | 300 | Indirect | By Son #1 |
| Common Stock, $0.10 Par Value | 300 | Indirect | By Son #2 |
Footnotes
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $49.28 to $49.375, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Shares held in custodial accounts for the benefit of Son #1 under the Uniform Transfer to Minors Act.
- Twenty-five percent of the stock option award vested on each of the first, second, third, and fourth anniversaries of the grant date, which was March 6, 2007.
Billionaire Hedge Funds
